Expanding the screening of newborns for detecting inborn errors in metabolism using next generation sequencing following mass spectrometry/immunoassay

A. Christy, Eatu Das, Jasmin Surana, Pradnya Padhye, Kedar Shirodkar, Rakhi Bajpai Dixit, Kirti Chadha
{"title":"Expanding the screening of newborns for detecting inborn errors in metabolism using next generation sequencing following mass spectrometry/immunoassay","authors":"A. Christy, Eatu Das, Jasmin Surana, Pradnya Padhye, Kedar Shirodkar, Rakhi Bajpai Dixit, Kirti Chadha","doi":"10.18231/j.ijcbr.2023.059","DOIUrl":null,"url":null,"abstract":"Inborn errors of metabolism are rare inherited disorders which leads to significant morbidity and mortality in patients. Very few studies have been conducted in India to assess prevalence of Inborn Errors of Metabolism (IEM) in newborns. We proposed testing by TMS/TR-FIA followed by NGS. This pilot study would be one of the first expanded NBS studies in India.The aim of this study was to determine the prevalence of IEM in newborns based on the samples received at Metropolis Global Reference Lab, India. Next-generation sequencing (NGS) was done as a confirmational analysis for patients tested presumptive positive on Newborn screening using Tandem Mass spectrometry (TMS) and Time-resolved fluoroimmunoassay (TR-FIA).  Two years retrospective study was conducted based on incidences of IEM using TMS and TR-FIA. NGS testing was performed on presumptive positive newborns for cystic fibrosis (CF), galactosemia and urea cycle disorder/ organic academia (UCD /OA) who had undergone NBS by TMS and TR-FIA. Highestprevalence of 1.98% & 1.58% was detected for G6PD and TSH respectively by TR-FIA. Prevalence of AA disorders (3.20%), OA (1.60%) and UCD (1.43%) was observed to be the highest amongst the diseases detected by TMS. Presumptive positive case of Argininemia and Cystic Fibrosis were found to be concordant with NGS. Out of three presumptive positive cases, one presumptive positive case of CF and two of galactose were found discordant.   Our prevalence study showed similarities to the prevalence reports published by other Asian countries. Expanded NBS program can be improved by including NGS as a first follow-up test after detection of abnormal metabolites in DBS. This approach will help in reducing the encumbrance of false-positive as well as false-negative cases. Our study will be influential in conducting more prospective studies and routine implementation of NGS-based analysis in NBS in India.","PeriodicalId":13899,"journal":{"name":"International Journal of Clinical Biochemistry and Research","volume":"721 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Biochemistry and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/j.ijcbr.2023.059","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Inborn errors of metabolism are rare inherited disorders which leads to significant morbidity and mortality in patients. Very few studies have been conducted in India to assess prevalence of Inborn Errors of Metabolism (IEM) in newborns. We proposed testing by TMS/TR-FIA followed by NGS. This pilot study would be one of the first expanded NBS studies in India.The aim of this study was to determine the prevalence of IEM in newborns based on the samples received at Metropolis Global Reference Lab, India. Next-generation sequencing (NGS) was done as a confirmational analysis for patients tested presumptive positive on Newborn screening using Tandem Mass spectrometry (TMS) and Time-resolved fluoroimmunoassay (TR-FIA).  Two years retrospective study was conducted based on incidences of IEM using TMS and TR-FIA. NGS testing was performed on presumptive positive newborns for cystic fibrosis (CF), galactosemia and urea cycle disorder/ organic academia (UCD /OA) who had undergone NBS by TMS and TR-FIA. Highestprevalence of 1.98% & 1.58% was detected for G6PD and TSH respectively by TR-FIA. Prevalence of AA disorders (3.20%), OA (1.60%) and UCD (1.43%) was observed to be the highest amongst the diseases detected by TMS. Presumptive positive case of Argininemia and Cystic Fibrosis were found to be concordant with NGS. Out of three presumptive positive cases, one presumptive positive case of CF and two of galactose were found discordant.   Our prevalence study showed similarities to the prevalence reports published by other Asian countries. Expanded NBS program can be improved by including NGS as a first follow-up test after detection of abnormal metabolites in DBS. This approach will help in reducing the encumbrance of false-positive as well as false-negative cases. Our study will be influential in conducting more prospective studies and routine implementation of NGS-based analysis in NBS in India.
在质谱/免疫测定之后使用新一代测序技术扩大新生儿筛查范围,以检测先天性代谢错误
先天性代谢异常是一种罕见的遗传性疾病,会导致患者严重的发病率和死亡率。印度很少有研究评估新生儿先天性代谢异常(IEM)的患病率。我们建议先进行 TMS/TR-FIA 检测,然后再进行 NGS 检测。这项试点研究将是印度首批扩大的 NBS 研究之一。这项研究的目的是根据印度 Metropolis 全球参考实验室收到的样本确定新生儿 IEM 的患病率。使用串联质谱(TMS)和时间分辨荧光免疫分析法(TR-FIA)对新生儿筛查推测阳性的患者进行了下一代测序(NGS)作为确证分析。 使用 TMS 和 TR-FIA 对 IEM 发病率进行了为期两年的回顾性研究。通过 TMS 和 TR-FIA 对囊性纤维化 (CF)、半乳糖血症和尿素循环障碍/有机学 (UCD /OA) 的推定阳性新生儿进行了 NGS 检测。通过 TR-FIA 检测,G6PD 和 TSH 的患病率最高,分别为 1.98% 和 1.58%。在 TMS 检测出的疾病中,AA 病(3.20%)、OA 病(1.60%)和 UCD 病(1.43%)的患病率最高。精氨酸血症和囊性纤维化的假定阳性病例与 NGS 一致。在三个推定阳性病例中,发现一个 CF 推定阳性病例和两个半乳糖推定阳性病例不一致。 我们的患病率研究与其他亚洲国家公布的患病率报告有相似之处。通过将 NGS 作为 DBS 检测到异常代谢物后的首次随访检测,可以改进 NBS 扩大计划。这种方法将有助于减少假阳性和假阴性病例。我们的研究将对开展更多前瞻性研究和在印度 NBS 中常规实施基于 NGS 的分析产生影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信